Colonoscopy? No thank you!

The diagnosis and severity grading of intestinal conditions such as Crohn’s disease typically require a complete colonoscopy with biopsy and relative histopathology exam. The VIGOR++ system makes possible to replace these invasive, unpleasant, and expensive exams with a simple magnetic resonance imaging session, followed by a patient-specific computer simulation.

The VIGOR++ software is now available for clinical research use via the 3Dnet™ medical imaging cloud service (www.3dnetmedical.com). Full-scale clinical trials are being designed at the Academic Medical Center, Amsterdam, and the UCL Hospital, London.

Tielbeek JA, Löwenberg M, Bipat S, Horsthuis K, Ponsioen CY, D'Haens GR, Stoker J. Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease. Inflamm Bowel Dis. 2013 Aug;19(9):1943-50. 10.1097/MIB.0b013e3182905536
Tielbeek, JA; Makanyanga, JC; Bipat, S; Pendsé, DA; Nio, CY; Vos, FM; Taylor, SA; Stoker, J; - (2013) Grading Crohn Disease Activity With MRI: Interobserver Variability of MRI Features, MRI Scoring of Severity, and Correlation With Crohn Disease Endoscopic Index of Severity. AJR Am J Roentgenol, 201 (6) 1220 - 1228. DOI:10.2214/AJR.12.10341
Mahapatra D, Schueffler P, Tielbeek J, Makanyanga J, Stoker J, Taylor S, VosF, Buhmann J., Automatic Detection and Segmentation of Crohn's Disease Tissues from Abdominal MRI, IEEE Trans Med Imaging. 2013.
Public dissemination: Euronews documentary www.euronews.com/2013/07/01/crohn-s-disease-the-inside-story 

Avicenna Alliance news

The EESC calls for the creation of Good Simulation Practices

The European Economic and Social Affairs Committee (EESC) has specifically called for the creation of Good Simulation Practices as part...

find out more ›

Avicenna continues to grow by welcoming Altair among its members!

The Avicenna Alliance is proud to announce the newest addition to its list of members: Altair!

Altair is a global technology...

find out more ›

Avicenna provides feedback on the processing of personal health data in the EU

During the month of July, the Avicenna Alliance received the opportunity to provide its contribution to the European...

find out more ›

The European Medicines Agency has accepted the Avicenna Alliance's request to be directly involved in Agency activities

We are proud to announce that the European Medicines Agency (EMA) has accepted...

find out more ›

The Avicenna Alliance provided feedback on the Pharmaceutical Strategy for Europe

We are proud to announce that the Avicenna Alliance has submitted Members’ feedback to the European Commission’s...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up